New once-weekly HIV pill matches daily treatment in phase 3 trial
|
Living with HIV often means taking antiretroviral
treatment every day to keep the virus under control. While modern HIV
medicines have made it ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.